HD Biosciences
Shanghai · Founded 2002
About HD Biosciences
HD Biosciences Inc. (HDB) is a Shanghai-based biotech company specializing in drug discovery contract research. HDB has developed extensive knowledge and comprehensive technology platforms for drug discovery including assay development, high throughput drug screening, SAR, closed-loop and hit-to-lead biology solutions, as well as natural product-based lead discovery. The Company has signed multiple-year research agreements with clients including Pfizer, Organon and other pharmaceutical and biotech clients and is an indisputable leader in high value-added biology-based drug discovery CRO business in China.
Company Facts
- Founded: 2002
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Series A (Aug 2008)
- Website: hdbiosciences.com
- Phone: 86 21 5116 3700
Social Profiles
Canonical: https://fsome.com/organization/hd-biosciences-8396134 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.